American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

J Low Genit Tract Dis. 2012 Jul;16(3):175-204. doi: 10.1097/LGT.0b013e31824ca9d5.

Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from six working groups, and a recent symposium co-sponsored by the ACS, American Society for Colposcopy and Cervical Pathology (ASCCP), and American Society for Clinical Pathology (ASCP), which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (e.g., management of screen positives and screening interval for screen negatives) of women after screening, age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16/18 infections.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • American Cancer Society
  • Biopsy, Needle
  • Cervical Intraepithelial Neoplasia / epidemiology
  • Cervical Intraepithelial Neoplasia / pathology
  • Colposcopy / methods*
  • Cytodiagnosis / standards
  • Early Detection of Cancer / standards*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Immunohistochemistry
  • Mass Screening / standards
  • Middle Aged
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / pathology
  • Practice Guidelines as Topic*
  • Risk Management
  • Societies, Medical / standards
  • United States
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / prevention & control*
  • Young Adult